Injection of Botulinum Toxin for Preventing Salivary Gland Toxicity after PSMA Radioligand Therapy: an Empirical Proof of a Promising Concept

The dose-limiting salivary gland toxicity of (225)Ac-labelled PSMA for treatment of metastatic, castration-resistant prostate cancer remains unresolved. Suppressing the metabolism of the gland by intraparenchymal injections of botulinum toxin appears to be a promising method to reduce off-target upt...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nucl Med Mol Imaging
Autores principales: Baum, Richard P., Langbein, Thomas, Singh, Aviral, Shahinfar, Mostafa, Schuchardt, Christiane, Volk, Gerd Fabian, Kulkarni, Harshad
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Berlin Heidelberg 2018
Materias:
Interesting Image
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777965/
https://ncbi.nlm.nih.gov/pubmed/29391917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13139-017-0508-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares